Literature DB >> 32699470

Patients With Type 2 Diabetes Are Willing to Do More to Overcome Therapeutic Inertia: Results From a Double-Blind Survey.

Steven V Edelman1, Richard Wood2, Michelle Roberts3, Jay H Shubrook4.   

Abstract

We performed a survey of 305 patients with type 2 diabetes receiving basal insulin and 240 physicians to measure key contrasts and similarities in patients' preferences and providers' beliefs and perceptions regarding insulin use. Many patients reported being more frustrated with their lack of treatment progress than physicians were aware of. Patients were also more likely to say they would do more than their physicians believed they would to better manage their diabetes. Identifying priorities and setting clear goals and timelines for achieving glycemic control could provide an opportunity to address these differences and reduce patients' frustration.
© 2020 by the American Diabetes Association.

Entities:  

Year:  2020        PMID: 32699470      PMCID: PMC7364461          DOI: 10.2337/cd19-0067

Source DB:  PubMed          Journal:  Clin Diabetes        ISSN: 0891-8929


  25 in total

Review 1.  Proportion of patients at HbA1c target <7% with eight classes of antidiabetic drugs in type 2 diabetes: systematic review of 218 randomized controlled trials with 78 945 patients.

Authors:  K Esposito; P Chiodini; G Bellastella; M I Maiorino; D Giugliano
Journal:  Diabetes Obes Metab       Date:  2011-11-03       Impact factor: 6.577

2.  Time to do more: addressing clinical inertia in the management of type 2 diabetes mellitus.

Authors:  W D Strain; X Cos; M Hirst; S Vencio; V Mohan; Z Vokó; D Yabe; M Blüher; P M Paldánius
Journal:  Diabetes Res Clin Pract       Date:  2014-05-27       Impact factor: 5.602

3.  American association of clinical endocrinologists and american college of endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015.

Authors:  Yehuda Handelsman; Zachary T Bloomgarden; George Grunberger; Guillermo Umpierrez; Robert S Zimmerman; Timothy S Bailey; Lawrence Blonde; George A Bray; A Jay Cohen; Samuel Dagogo-Jack; Jaime A Davidson; Daniel Einhorn; Om P Ganda; Alan J Garber; W Timothy Garvey; Robert R Henry; Irl B Hirsch; Edward S Horton; Daniel L Hurley; Paul S Jellinger; Lois Jovanovič; Harold E Lebovitz; Derek LeRoith; Philip Levy; Janet B McGill; Jeffrey I Mechanick; Jorge H Mestman; Etie S Moghissi; Eric A Orzeck; Rachel Pessah-Pollack; Paul D Rosenblit; Aaron I Vinik; Kathleen Wyne; Farhad Zangeneh
Journal:  Endocr Pract       Date:  2015-04       Impact factor: 3.443

4.  Clinical inertia contributes to poor diabetes control in a primary care setting.

Authors:  David C Ziemer; Christopher D Miller; Mary K Rhee; Joyce P Doyle; Clyde Watkins; Curtiss B Cook; Daniel L Gallina; Imad M El-Kebbi; Catherine S Barnes; Virginia G Dunbar; William T Branch; Lawrence S Phillips
Journal:  Diabetes Educ       Date:  2005 Jul-Aug       Impact factor: 2.140

5.  The IMPROVE study--a multinational, observational study in type 2 diabetes: baseline characteristics from eight national cohorts.

Authors:  P Valensi; M Benroubi; V Borzi; J Gumprecht; R Kawamori; J Shaban; S Shah; M Shestakova; Y Wenying
Journal:  Int J Clin Pract       Date:  2008-09-22       Impact factor: 2.503

6.  Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Authors:  Melanie J Davies; David A D'Alessio; Judith Fradkin; Walter N Kernan; Chantal Mathieu; Geltrude Mingrone; Peter Rossing; Apostolos Tsapas; Deborah J Wexler; John B Buse
Journal:  Diabetologia       Date:  2018-12       Impact factor: 10.122

7.  10-year follow-up of intensive glucose control in type 2 diabetes.

Authors:  Rury R Holman; Sanjoy K Paul; M Angelyn Bethel; David R Matthews; H Andrew W Neil
Journal:  N Engl J Med       Date:  2008-09-10       Impact factor: 91.245

8.  Exploring the role of the patient-physician relationship on insulin adherence and clinical outcomes in type 2 diabetes: Insights from the MOSAIc study.

Authors:  Bruno Linetzky; Dingfeng Jiang; Martha M Funnell; Bradley H Curtis; William H Polonsky
Journal:  J Diabetes       Date:  2016-08-17       Impact factor: 4.006

9.  How to engage type-2 diabetic patients in their own health management: implications for clinical practice.

Authors:  Guendalina Graffigna; Serena Barello; Chiara Libreri; Claudio A Bosio
Journal:  BMC Public Health       Date:  2014-06-25       Impact factor: 3.295

10.  Clinical inertia with regard to intensifying therapy in people with type 2 diabetes treated with basal insulin.

Authors:  K Khunti; A Nikolajsen; B L Thorsted; M Andersen; M J Davies; S K Paul
Journal:  Diabetes Obes Metab       Date:  2016-02-09       Impact factor: 6.577

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.